These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19924590)

  • 1. Effectiveness of intramuscular aripiprazole injection in patients with catatonia: report on three cases.
    Voros V; Kovacs A; Herold R; Osvath P; Simon M; Fekete S; Tenyi T
    Pharmacopsychiatry; 2009 Nov; 42(6):286-7. PubMed ID: 19924590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of aripiprazole in the treatment of catatonia].
    Vörös V; Tényi T
    Neuropsychopharmacol Hung; 2010 Jun; 12(2):373-6. PubMed ID: 20606247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful switch from clozapine to aripiprazole: a case report.
    Jong-Yih L
    J Clin Psychopharmacol; 2009 Feb; 29(1):93-5. PubMed ID: 19142120
    [No Abstract]   [Full Text] [Related]  

  • 5. Catatonia resolution and aripiprazole.
    Bastiampillai T; Dhillon R
    Aust N Z J Psychiatry; 2008 Oct; 42(10):907. PubMed ID: 18777237
    [No Abstract]   [Full Text] [Related]  

  • 6. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dosage of aripiprazole-induced dysphagia.
    Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
    Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
    Prescrire Int; 2009 Dec; 18(104):251. PubMed ID: 20025091
    [No Abstract]   [Full Text] [Related]  

  • 9. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of catatonia with aripiprazole in an adolescent with psychosis.
    Strawn JR; Delgado SV
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):733-5. PubMed ID: 17979595
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report.
    Kirino E
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):185-8. PubMed ID: 20880829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of high-dose aripiprazole in treatment-refractory schizophrenic patients.
    Crossman AM; Lindenmayer JP
    J Clin Psychiatry; 2006 Jul; 67(7):1158-9. PubMed ID: 16889465
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder.
    Angelopoulos EK; Corcondilas M; Kollias CT; Kioulos KT; Bergiannaki JD; Papadimitriou GN
    J Clin Psychopharmacol; 2010 Dec; 30(6):745-6. PubMed ID: 21057243
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
    J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supersensitivity psychosis after tapering aripiprazole: a case report.
    Chang CC; Hsu WY; Chen SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):388-9. PubMed ID: 19166895
    [No Abstract]   [Full Text] [Related]  

  • 17. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
    Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.
    Sokolski KN
    Ann Pharmacother; 2011 Jul; 45(7-8):e36. PubMed ID: 21672885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.
    Andersen SE; Johansson M; Manniche C
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):75-81. PubMed ID: 18346047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study.
    Pae CU; Serretti A; Chiesa A; Mandelli L; Lee C; Lee C; Kim J; De Ronchi D; Paik IH
    Eur Neuropsychopharmacol; 2009 Aug; 19(8):562-70. PubMed ID: 19442491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.